RecruitingPhase 3ACTRN12612000166875

Does progesterone support in luteal phase deficiency help subfertile couples achieve a pregnancy?

In women with unexplained subfertility and luteal phase deficiency, does luteal phase support with progesterone while using a fertility awareness-based charting method when compared to fertility awareness-based charting alone increase the likelihood of pregnancy?


Sponsor

Dr Luke McLindon

Enrollment

180 participants

Start Date

Feb 7, 2012

Study Type

Interventional

Conditions

Summary

This project aims to assess the effectiveness of progesterone as luteal phase support in unexplained subfertile women with a previously diagnosed luteal phase hormonal deficiency. All women will be instructed in a fertility awareness-based charting method (the Sympto-Thermal method). It is hypothesised that progesterone given as luteal phase support increases the likelihood of pregnancy in unexplained subfertile women with a recognised luteal phase hormonal defect.


Eligibility

Sex: FemalesMin Age: 18 Yearss

Inclusion Criteria4

  • Luteal phase hormonal defect (based on oestradiol and progesterone serum levels drawn on days 5, 7 and 9 post-ovulation) AND
  • A. Failing to achieve a pregnancy after 12 months of unprotected random intercourse OR
  • B. Failing to achieve an ongoing pregnancy (greater than 20 weeks) after 12 months of unprotected random intercourse OR
  • C. A history of 3 or more miscarriages

Exclusion Criteria6

  • Subfertility is due to tubal causes (defined as abnormal hysterosalpingography and/or laparoscopy & dye insufflation, and/or hysterosalpingography with contrast by sonography (HyCoSy))
  • Subfertility is due to male factor (absence of a normal /effective seminal fluid analysis within last six months (WHO criteria))
  • Women who are exclusively breastfeeding
  • Currently using contraception
  • Currently pregnant
  • Currently using any prescribed fertility-enhancing medications or supplements, including Vitex agnus

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Progesterone pessaries (400 mg vaginally nightly) during each luteal phase (used for 10 consecutive nights), for up to 8 months/cycles. Formal instruction in the Sympto-Thermal Method is routinely

Progesterone pessaries (400 mg vaginally nightly) during each luteal phase (used for 10 consecutive nights), for up to 8 months/cycles. Formal instruction in the Sympto-Thermal Method is routinely provided.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000166875


Related Trials